Wider compensation gap between male and female physicians seen in 2019 versus 2013
WEDNESDAY, Oct. 5, 2022 (HealthDay News) — Male physicians receive significantly higher payments from the highest-grossing medical industry companies compared with female physicians, according to a study published online Sept. 28 in JAMA Surgery.
Brittany G. Sullivan, M.D., from the University of California at Irvine, and colleagues investigated payments made from the highest-grossing medical industry companies to female and male physicians and assessed compensation and engagement disparities based on gender. The analysis included data from the Open Payments database for the five female and five male physicians who received the most financial compensation from each of the 15 highest-grossing U.S. medical supply companies (January 2013 to January 2019; 1,050 payments).
The researchers found that 96.9 percent of the five highest earners were men and only 3.1 percent were women. Mean payments for female physicians were $41,320 compared with $1.23 million for male physicians. Across all medical specialties — including female-dominated specialties — and academic ranks, this disparity persisted. Male gender was significantly associated with higher payment when adjusting for rank, h-index, and specialty. The payment gap between female and male physicians increased from $54,343 in 2013 to $166,778 in 2019.
“Future studies are needed to elucidate why the gender gap in medical industry payments continues to widen despite national recognition and more women in medicine,” the authors write.
Two authors disclosed financial ties to the medical industry.
Abstract/Full Text (subscription or payment may be required)
Pediatricians Report Immigrant Families Avoiding Care for Their Children
Psychiatrists Only Agree 55 Percent of the Time on Diagnoses
Napping Opportunity May Improve Clinical Performance of Anesthesia Residents
2021 to 2025 Saw Reduction in Burnout Indicators Among Pediatricians
Physical Exams May Not Reliably Diagnose Pediatric Pneumonia
Barriers to Pediatric Cancer Clinical Trial Participation Identified
Guidance Provided for Transition From Pediatric to Adult Endocrine Care
Weekly, High-Risk Rounds Reduced Hospital-Acquired Conditions in Pediatric ICU